"Moreover , government officials say , companies in such deals must take significant financial risks and expenditures on their own , without any guarantee that companies in such deals drug will be approved .Kite says it has spent more than Kite 200 Kite on research and development , including running larger clinical trials than those conducted by the cancer institute , and recently spent about $ 30 million to build a factory that will be able to make treatments for up to 5 , 000 patients a year .Setting the price of the drug , Dr. Rosenberg said , the drug for the marketplace .